← All companies
Earnings thesis change · rubric v1.0

PG PROCTER & GAMBLE Co

Fiscal Q1 FY2027 · quarter ended September 30, 2026 · reported 2026-10-22
SEC filings and exhibits only
Earnings filing (8-K) · Latest 10-Q filings
Last updated: Oct 22, 2026 at 7:03 PM UTC
ACCOUNTING RISK · CLEAR No auditor changes, restatements, late filings, or listing notices in the last 12 months. from SEC filings · 2026-10-09
Thesis change

Unchanged

Legacy analysis
Guidance0

Current guidance was classified as maintained.

Low confidence

Legacy analysis: only the dimensions classifiable by the pre-v1 pipeline are shown.

Reported facts

GAAP facts are reported by the company. Comparable figures are EarnIQ arithmetic using only quantified adjustments disclosed in the linked SEC exhibit.

Reported EPS and revenue have not yet been extracted from the filing.

Earnings quality

From 10-Q / 10-K XBRL filings. Sloan (1996) accruals: high accruals relative to assets have historically preceded earnings disappointments. Descriptive research, not a prediction.

5 / 5
Strong — cash is doing the heavy lifting
Earnings look cash-backed — accruals are -11.4% of assets, in the strongest quintile of large caps.
CY2017Q4Accruals / assets (TTM)CY2019Q3

Depreciation is disclosed annually by most filers, so quarterly values blend actuals with estimates — flagged on every reading. Method: TTM Sloan accruals ÷ average assets, scored 1–5 by quintile.

1. Three decisive changes

Largest quantified changes versus the company's own history.

-20.3%
Operating income — year over year

$4.6B vs $5.7B a year ago · quarter ended Mar 31, 2026 · from 10-Q XBRL filings.

-15.1%
Net income — year over year

$3.9B vs $4.6B a year ago · quarter ended Mar 31, 2026 · from 10-Q XBRL filings.

-3.0%
Revenue — year over year

$21.2B vs $21.9B a year ago · quarter ended Mar 31, 2026 · from 10-Q XBRL filings.

2. Was it already expected?

Consensus classifications require timestamped pre-report snapshots and eight-quarter surprise history.

ItemActualExpectedGapClass
Consensus comparison coming soon.

3. Management consistency

Only attributable, measurable and dated commitments are counted. Delivery record: 3 being tracked.

PromiseTargetOutcomeStatusEvidence
Expects to incur approximately $2 billion in before-tax restructuring costs over two years, with the remainder expected to be incurred in fiscal 2027other · made 2026-10-22~$2 billionFY 2027—Pending8-K 0000080424-26-0002
Expects FY 2027 Core EPS growth of -% to +3%eps · made 2026-10-22-% to +3%FY 2027—Pending8-K 0000080424-26-0002
Expects FY 2027 organic sales growth of +1% to +3%revenue · made 2026-10-22+1% to +3%FY 2027—Pending8-K 0000080424-26-0002

4. What matters next

One deciding measurable condition plus up to two supporting checkpoints.

The deciding condition

EPS for the guided period lands within $6.89–$7.11

StrengthensReported EPS above $7.11
InvalidatesReported EPS below $6.89
Guidance in management's words

P&G updated all-in sales growth guidance to 2% to 4% incorporating the Thorne acquisition, while maintaining organic sales growth of 1% to 3% and core EPS of $6.89 to $7.11.

5. Risks that changed

New or materially worsened items only; unchanged boilerplate is omitted.

No new or materially worsened risk has been source-verified.
From 10-K filings · EDGAR
4
new risk disclosures added
6
old ones removed

FY2026 10-K vs prior year, boilerplate filtered out — these are idiosyncratic changes, and tone is slightly more negative.

New risk disclosure #1

“Our business results depend on our ability to manage disruptions in our global supply chain. Our ability to meet our customers’ needs and achieve cost targets depends on our ability to maintain key manufacturing and supp…”

New risk disclosure #2

“Our ability to meet our growth targets depends on successful product, marketing and operations innovation and successful responses to competitive innovation, evolving digital marketing and selling platforms and changing …”

New risk disclosure #3

“Our business is subject to numerous risks as a result of having significant operations and sales in international markets, including foreign currency fluctuations, currency exchange or pricing controls. We are a global c…”

6. Evidence drawer

Source location, short anchor and visible arithmetic for every verified claim.

DC1 10-Q / 10-K XBRL filings (US-GAAP, via EDGAR)
Operating income · quarter ended 2026-03-31
Operating income: -20.3% year over year
(4,576,000,000 − 5,741,000,000) ÷ 5,741,000,000 = -20.3% YoY
DC2 10-Q / 10-K XBRL filings (US-GAAP, via EDGAR)
Net income · quarter ended 2026-03-31
Net income: -15.1% year over year
(3,932,000,000 − 4,630,000,000) ÷ 4,630,000,000 = -15.1% YoY
DC3 10-Q / 10-K XBRL filings (US-GAAP, via EDGAR)
Revenue · quarter ended 2026-03-31
Revenue: -3.0% year over year
(21,235,000,000 − 21,882,000,000) ÷ 21,882,000,000 = -3.0% YoY
WN1 8-K Exhibit 99.1 (earnings release, via EDGAR)
Guidance disclosed for Q1 FY2027
EPS for the guided period lands within $6.89–$7.11
Strengthens: Reported EPS above $7.11 · Invalidates: Reported EPS below $6.89